Literature DB >> 9010724

CTLA-4, a negative regulator of T-lymphocyte activation.

P Waterhouse1, L E Marengère, H W Mittrücker, T W Mak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9010724     DOI： 10.1111/j.1600-065x.1996.tb00925.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  13 in total

Review 1.  Function and regulation of memory CD4 T cells.

Authors:  D P Metz; K Bottomly
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.

Authors:  A Merlo; D Saverino; C Tenca; C E Grossi; S Bruno; E Ciccone
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.

Authors:  Dirk Homann; Wolfgang Dummer; Tom Wolfe; Evelyn Rodrigo; Argyrios N Theofilopoulos; Michael B A Oldstone; Matthias G von Herrath
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Cytotoxic T lymphocyte antigen-4 regulates development of xenogenic graft versus host disease in mice via modulation of host immune responses induced by changes in human T cell engraftment and gene expression.

Authors:  Chunxu Gao; Debra Gardner; Marie-Clare Theobalds; Shannon Hitchcock; Heather Deutsch; Chidozie Amuzie; Matteo Cesaroni; Davit Sargsyan; Tadimeti S Rao; Ravi Malaviya
Journal:  Clin Exp Immunol       Date:  2021-09-22       Impact factor: 4.330

Review 5.  Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.

Authors:  P Scheipers; H Reiser
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Low concentrations of lipopolysaccharide synergize with peptides to augment human T-cell proliferation and can prevent the induction of non-responsiveness by CTLA4-Ig.

Authors:  M R Goodier; M Londei
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

7.  Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndrome.

Authors:  Heather M Gibson; Anjali Mishra; Derek V Chan; Timothy S Hake; Pierluigi Porcu; Henry K Wong
Journal:  J Invest Dermatol       Date:  2012-09-06       Impact factor: 8.551

8.  No evidence for dualism in function and receptors: PD-L2/B7-DC is an inhibitory regulator of human T cell activation.

Authors:  Katharina Pfistershammer; Christoph Klauser; Winfried F Pickl; Johannes Stöckl; Judith Leitner; Gerhard Zlabinger; Otto Majdic; Peter Steinberger
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

9.  Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.

Authors:  P J Lucas; S J Kim; S J Melby; R E Gress
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

10.  Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.

Authors:  W Chen; W Jin; S M Wahl
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.